Table 3.
EBV-positive NLPHL reported in the literature
| Authors | Country | NLPHL*
cases total tested |
NLPHL cases positive, number (%) |
Patient ages studied |
EBV testing method |
|---|---|---|---|---|---|
| Pallesen et al. 1991 (8) | Denmark | 10 | 1 (10) | NR | LMP1 |
| Herbst et al. 1992 (9) | Germany | 2 | 2 (100) | NR | EBER, LMP1 |
| Murray et al. 1992 (10) | UK | 12 | 1 (8) | NR | LMP1 |
| Weinreb et al. 1992 (11) | UK | 13 | 4 (31) | Children | LMP1 |
| Ambinder et al. 1993 (12) | Honduras | 1 | 1 (100) | Child | EBER, LMP1 |
| USA | 2 | 0 | Children | ||
|
+Preciado MV et al. 1995 (20) |
Argentina | 6 | 1 (17) | Children | LMP1 |
|
+Preciado MV et al. 1995 (13) |
Argentina | 6 | 2 (33) | Children | LMP1, EBER |
| Huh J et al. 1996 (14) | Korea | 1 | 1 | Adult | EBER |
|
*Weinreb et al. 1996 (16) |
Multinational | 31 | 15 (48) | Children | LMP1 |
| *Weinreb et al. 1996 (15) | Kenya | 2 | 2 (100) | Children | LMP1 |
| 3 | 2 (67) | Adults | |||
| Andriko JA et al. 1997 (17) | USA | 16 | 1 (6) | Children | LMP1 |
|
+Preciado MV et al. 1997 (19) |
Argentina | 8 | 2 (25) | Children | LMP1, EBER |
| Chang et al. 2005 (7) | Vietnam | 3 | 3 (100) | Children | EBER |
| Nam-Cha et al. 2009 (18) | Spain | 57 | 1 (2) | NR | EBER |
| Current study | USA & Canada |
301 | 11 (4) | All ages | EBER, LMP1 |
NR = not reported; ISH = in-situ hybridization; IHC = immunohistochemistry.
+
, = It is unclear from the literature whether reports with the same first author include previously published case.
*
= It is unclear from the literature whether reports with the same first author include previously published case.